CN103169938A - Drug for treating scapulohumeral periarthritis - Google Patents

Drug for treating scapulohumeral periarthritis Download PDF

Info

Publication number
CN103169938A
CN103169938A CN2013101302339A CN201310130233A CN103169938A CN 103169938 A CN103169938 A CN 103169938A CN 2013101302339 A CN2013101302339 A CN 2013101302339A CN 201310130233 A CN201310130233 A CN 201310130233A CN 103169938 A CN103169938 A CN 103169938A
Authority
CN
China
Prior art keywords
parts
drug
scapulohumeral periarthritis
shoulder
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013101302339A
Other languages
Chinese (zh)
Inventor
薛洪喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013101302339A priority Critical patent/CN103169938A/en
Publication of CN103169938A publication Critical patent/CN103169938A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a drug for treating scapulohumeral periarthritis. The common symptoms of the scapulohumeral periarthritis are omodynia and dyskinesia. The right shoulder morbidity is a little higher than the left shoulder; the scapulohumeral periarthritis is related to deficiency of qi and blood, and wind-cold damp pathogen hit or trauma strain, and has an acute pain stage and a chronic stiffness stage; the deltoideus triangularis shrinks a little in physical examination; and the trapezius cramps, shoulder osteoporosis or supraspinatus tendon and shoulder peak decline capsule calcification can be seen through an X-ray pain film. The inventor finally finds out the traditional Chinese medicine oral drug with a better curative effect for treating scapulohumeral periarthritis by a long-range research and clinical verification. The dosage of the drug component disclosed by the invention is fumbled by the inventor; the optimum proportions are 30 parts of rehmannia glutinosa, 15 parts of cornu cervi degelatinatum, 9 parts of cassia twig, 9 parts of baked ginger, 9 parts of ephedra, 10 parts of semen brassicae, 10 parts of zedoary, 10 parts of myrrh, 10 parts of notopterygium root and 6 parts of honey-fried licorice root. By adopting these drug compositions, each drug generates the synergistic effect, and the drug has the effects of warming and promoting channels, promoting the circulation of qi and removing stasis, and promoting blood circulation to arrest pain, so as to effectively treat the scapulohumeral periarthritis.

Description

A kind of medicine of cure scapulohumeral periarthritis
Technical field
The present invention relates to a kind of Chinese herbal medicine, especially a kind of Chinese herbal medicine of cure scapulohumeral periarthritis.
Background technology
The scapulohumeral periarthritis common sympton is shoulder pain and dyskinesia, and the women is more than the male, and right shoulder morbidity is slightly more than left shoulder, many and insufficiency of vital energy and blood, wind-cold damp pathogen invasion and attack or wound strain are relevant, minute acute pain phase and chronic stiff phase, are more common in 50 years old left and right middle-aged and elderly people.Have a medical check-up and see the slight atrophy of triangular muscle, trapezius muscle spasm.The visible shoulder osteoporosis of x-ray plain film or tendon of supraspinatus muscle, subacromial bursa calcification are levied.
Summary of the invention
The inventor is through studying for a long period of time, and, by the checking repeatedly of clinical trial, finally found the extract oral medicine that is used for the treatment of scapulohumeral periarthritis that better curative effect is arranged, and this medicine has promoting the flow of QI-blood by warming the meridian, circulation of qi promoting removing blood stasis with potent drugs, promoting blood circulation and stopping pain curative effect.
Technical assignment of the present invention is to provide a kind of Chinese medicine composition of more efficiently cure scapulohumeral periarthritis.Medicament selection Radix Rehmanniae Preparata of the present invention, Cornu Cervi Degelatinatum, Ramulus Cinnamomi, Rhizoma Zingiberis Preparatum, Herba Ephedrae, Semen Sinapis Albae, Rhizoma Wenyujin Concisum, Myrrha, Rhizoma Et Radix Notopterygii, Radix Glycyrrhizae Preparata are combined, and make each efficacy of drugs produce synergism these drug regimens, thus effective cure scapulohumeral periarthritis.Wherein: Radix Rehmanniae Preparata: for Radix Rehmanniae is mixed steaming to inside and outside darkish complexion, glossy through adding yellow wine, or directly steaming forms to deceiving profit.Property is sweet, tepor.Return the Liver and kidney warp.The YIN nourishing of enriching blood, beneficial essence is filled out marrow.
Cornu Cervi Degelatinatum: be the remove photoresist hornblock of matter of Cornu Cervi.Property is salty, puckery, temperature.Return liver, kidney channel.Warming the kidney to activate YANG, astringing to arrest bleeding.
Ramulus Cinnamomi: be the twig of Lauraceae magaphanerophytes Cortex Cinnamomi.The property acrid, sweet, warm.Return lung, the heart, kidney,liver,spleen warp.There is relieving the exterior syndrome by diaphoresis, promoting the flow of QI-blood by warming the meridian, the effect of warm aid yang qi.
Rhizoma Zingiberis Preparatum: be the old root processed product of the drying of Rhizoma Zingiberis Recens, with the Rhizoma Zingiberis stir-baking in sand to heaving, surperficial sepia.The property bitter, puckery, temperature.Return spleen, Liver Channel.Warming the meridian for stopping bleeding, warming middle-JIAO to relieve pain.
Herba Ephedrae: be the herb stem of Ephedraceae draft shape undershrub Ephedra sinica, ephedra equisetina and epheday intermedia.The property hot, micro-hardship, temperature.Return lung, urinary bladder channel.Relieving the exterior syndrome by diaphoresis, depressed lung-energy dispersing, inducing diuresis to remove edema.
Semen Sinapis Albae: for Cruciferae is annual or get over year seed of this plant of SHENGCAO Caulis et Folium Sinapis albee.The property suffering, temperature.Attach to the lung and stomach meridians.Warming the lung for resolving phlegm, the promoting the circulation of QI eliminating stagnation.
Rhizoma Wenyujin Concisum: be the rhizome of zingiberaceous plant Rhizoma Curcumae Longae.The property hot, bitter, temperature.The circulation of qi promoting removing blood stasis with potent drugs, inducing menstruation to relieve menalgia.
Myrrha: the oleo-gum-resin of oozing out for Burseraceae shrub or arbor myrrh skin zone.The property hot, bitter, flat.GUIXIN, liver, spleen channel.Promoting blood circulation and stopping pain, detumescence and promoting granulation.
Rhizoma Et Radix Notopterygii: be rhizome and the root of Umbelliferae herbaceos perennial Rhizoma Et Radix Notopterygii and Radix et Rhizoma Notopterygii.The property hot, bitter, temperature.Return bladder, kidney channel.Cold expelling dispels the wind, and gives birth to wet pain relieving.
Radix Glycyrrhizae Preparata: be the rhizome of pulse family herbaceos perennial Radix Glycyrrhizae.Property is sweet, is slightly cold.GUIXIN, lung, spleen, stomach warp.Reinforcing the heart temper, relieving spasm to stop pain, heat-clearing and toxic substances removing, the mediation property of medicine.
The consumption of drug component of the present invention also gropes to draw through the inventor in a large number, and each amounts of components is for to have curative effect preferably in the following weight proportioning: Radix Rehmanniae Preparata 10-30 part, Cornu Cervi Degelatinatum 10-15 part, Ramulus Cinnamomi 5-15 part, Rhizoma Zingiberis Preparatum 3-9 part, Herba Ephedrae 3-10 part, Semen Sinapis Albae 3-10 part, Rhizoma Wenyujin Concisum 3-10 part, Myrrha 3-10 part, Rhizoma Et Radix Notopterygii 3-10 part, Radix Glycyrrhizae Preparata 5-10 part.
Its best proportioning is: 30 parts, Radix Rehmanniae Preparata, 15 parts of Cornu Cervi Degelatinatums, 9 parts of Ramulus Cinnamomi, 9 parts of Rhizoma Zingiberis Preparatums, 9 parts, Herba Ephedrae, 10 parts of Semen Sinapis Albaes, 10 parts of Rhizoma Wenyujin Concisum, 10 parts of Myrrhas, 10 parts of Rhizoma Et Radix Notopterygiis, 6 parts of Radix Glycyrrhizae Preparatas.
Medicine of the present invention can adopt the conventional method of Chinese medicine preparation to be prepared into any conventional oral preparations, as pill, powder, tablet, oral liquid etc.For example these crude drug pulverize mix homogeneously can be made to powder takes after mixing it with water; Can use decocting, obtain after filtration filtrate, make oral liquid; Also can directly take decoction in case of necessity.
Medicine of the present invention has the effect of promoting the flow of QI-blood by warming the meridian, circulation of qi promoting removing blood stasis with potent drugs, promoting blood circulation and stopping pain, short treating period, evident in efficacy, without any side effects, according to clinical 210 routine patients are observed to statistics, take 84.76%, three of 75.24%, two of one of the medicine of the present invention obvious effective rate course for the treatment of obvious effective rate course for the treatment of obvious effective rate course for the treatment of 92.86%.
The specific embodiment
Take following each medicine:
30 parts, Radix Rehmanniae Preparata, 15 parts of Cornu Cervi Degelatinatums, 9 parts of Ramulus Cinnamomi, 9 parts of Rhizoma Zingiberis Preparatums, 9 parts, Herba Ephedrae, 10 parts of Semen Sinapis Albaes, 10 parts of Rhizoma Wenyujin Concisum, 10 parts of Myrrhas, 10 parts of Rhizoma Et Radix Notopterygiis, 6 parts of Radix Glycyrrhizae Preparatas.
Said medicine is put in mortar and ground well successively, cross 100 mesh sieves, then packing two pouches; While taking one day twice once a bag, 15 days is a course for the treatment of.
Below the clinical data that the patient uses medicine of the present invention:
One, physical data
Accept patient's totally 210 examples for medical treatment, all make a definite diagnosis on inspection, its age 36-65 year, average 45 years old.
Two, diagnostic criteria
1, shoulder pain and dyskinesia, the women is more than the male, and right shoulder morbidity is slightly more than left shoulder.Many and insufficiency of vital energy and blood, wind-cold damp pathogen invasion and attack or wound strain are relevant.Divide acute pain phase and chronic stiff phase, be more common in 50 years old left and right middle-aged and elderly people.2, the slight atrophy of triangular muscle, the trapezius muscle spasm.3, the visible shoulder osteoporosis of x-ray plain film or tendon of supraspinatus muscle, subacromial bursa calcification are levied.
Three, Therapeutic Method
The patient takes medicine of the present invention, and one day twice, once a bag.
Four, efficacy assessment standard
Produce effects: after finishing the course for the treatment of, clinical symptoms disappears fully.
Take a turn for the better: symptom is alleviated substantially.
Invalid: remission is not obvious.
Five, therapeutic outcome
Treatment time Produce effects (example) Obvious effective rate % Take a turn for the better (example) Improvement rate % Invalid (example) Inefficiency %
One course for the treatment of 158 75.24 42 20.00 10 4.76
Two courses for the treatment of 178 84.76 24 11.44 8 3.80
Three courses for the treatment of 195 92.86 10 4.76 5 2.38
Model case:
One, Mrs Li, 48 years old, the From Shandong Rizhao people, right shoulder pain and dyskinesia, have a medical check-up and see the slight atrophy of triangular muscle, trapezius muscle spasm.The visible shoulder osteoporosis of x-ray plain film, subacromial bursa calcification are levied.
Take medicine of the present invention after course for the treatment of, patient's shoulder pain stops, and the dyskinesia alleviates, and continues to take medicine of the present invention after course for the treatment of, and shoulder pain disappears, and without moving obstacle, continues to consolidate a course for the treatment of curative effect.
Two, Ms Zhang, 57 years old, Shandong Zibo people, right shoulder pain and dyskinesia, the slight atrophy of the triangular muscle of having a medical check-up, the trapezius muscle spasm, the visible shoulder osteoporosis of x-ray plain film, tendon of supraspinatus muscle, subacromial bursa calcification are levied.
Take medicine of the present invention after course for the treatment of, the patient feels symptom obviously to be alleviated, and head movement and shoulder pain obviously alleviate, and shoulder pain disappears, and continues to take medicine of the present invention after course for the treatment of, and shoulder pain stops, and continues to consolidate a course for the treatment of curative effect.

Claims (2)

1. the medicine of a cure scapulohumeral periarthritis, is characterized in that it is made by the crude drug of following weight proportion: Radix Rehmanniae Preparata 10-30 part, Cornu Cervi Degelatinatum 10-15 part, Ramulus Cinnamomi 5-15 part, Rhizoma Zingiberis Preparatum 3-9 part, Herba Ephedrae 3-10 part, Semen Sinapis Albae 3-10 part, Rhizoma Wenyujin Concisum 3-10 part, Myrrha 3-10 part, Rhizoma Et Radix Notopterygii 3-10 part, Radix Glycyrrhizae Preparata 5-10 part.
2. medicine according to claim 1 is characterized in that it is made by the crude drug of following weight proportion:
30 parts, Radix Rehmanniae Preparata, 15 parts of Cornu Cervi Degelatinatums, 9 parts of Ramulus Cinnamomi, 9 parts of Rhizoma Zingiberis Preparatums, 9 parts, Herba Ephedrae, 10 parts of Semen Sinapis Albaes, 10 parts of Rhizoma Wenyujin Concisum, 10 parts of Myrrhas, 10 parts of Rhizoma Et Radix Notopterygiis, 6 parts of Radix Glycyrrhizae Preparatas.
CN2013101302339A 2013-04-16 2013-04-16 Drug for treating scapulohumeral periarthritis Pending CN103169938A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013101302339A CN103169938A (en) 2013-04-16 2013-04-16 Drug for treating scapulohumeral periarthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013101302339A CN103169938A (en) 2013-04-16 2013-04-16 Drug for treating scapulohumeral periarthritis

Publications (1)

Publication Number Publication Date
CN103169938A true CN103169938A (en) 2013-06-26

Family

ID=48630425

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013101302339A Pending CN103169938A (en) 2013-04-16 2013-04-16 Drug for treating scapulohumeral periarthritis

Country Status (1)

Country Link
CN (1) CN103169938A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1457820A (en) * 2002-05-14 2003-11-26 常顶峰 Pill for eliminating stagnation and pains
CN102600385A (en) * 2012-03-03 2012-07-25 刘天岐 Lycopodium clavatum pain relieving tablet

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1457820A (en) * 2002-05-14 2003-11-26 常顶峰 Pill for eliminating stagnation and pains
CN102600385A (en) * 2012-03-03 2012-07-25 刘天岐 Lycopodium clavatum pain relieving tablet

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
朴哲: "《家用妙方大全》", 31 March 1993, article "肩周炎属寒湿流注痰浊淤阻型用地霜汤", pages: 267 *

Similar Documents

Publication Publication Date Title
CN103169805A (en) Medicament for treating meniscus injury
CN103157051B (en) Medicament for treating vaginitis
CN103071042B (en) Traditional Chinese medicinal preparation for treating diabetes
CN103705878A (en) Migraine treatment traditional Chinese medicine preparation
CN102847048A (en) Medicine for treating superficial gastritis and preparation method thereof
CN103893725A (en) Traditional Chinese medicine for treating spleen and kidney Yang insufficiency type idiopathic edema
CN102038751A (en) Traditional Chinese medicine formulation for treating infantile diarrhea
CN103169940B (en) Drug for treating facioplegia
CN102225118A (en) Blood-activating wind-dispelling liquid
CN105456924A (en) Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof
CN105381289A (en) Pharmaceutical composition for treating abnormal menstruation
CN105169279A (en) Traditional Chinese medicine composition for treating knee joint bone hyperplasia
CN101530598B (en) Plaster used for hyperosteogeny
CN103169938A (en) Drug for treating scapulohumeral periarthritis
CN104474516A (en) Traditional Chinese medicine preparation for treating urticaria as well as preparation method and application of traditional Chinese medicine preparation
CN104491288A (en) Traditional Chinese medicine preparation for treating dysmenorrhea and preparation method and application thereof
CN103211909A (en) Traditional Chinese medicine composition for treating dandruff
CN102614348A (en) Chinese medicine for treating cold-damp affecting spleen diarrhea
CN101983712A (en) Novel medicament for treating coronary heart disease
CN1879811B (en) Chinese medicinal composition for treating epilepsy
CN103169899B (en) Drug for treating hydrops articuli
CN1049599C (en) Medicine for treatment of thromboangiitis obliterans
CN104758346A (en) Medicine for treating migraine, as well as preparation method and preparation of medicine
CN105267552A (en) Traditional Chinese medicine for facilitating excretion of stomach and intestine image contrast agent
CN101837115B (en) Steamed and applied traditional Chinese medicine for promoting recovery after restoration of prolapse of lumbar intervertebral disc

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130626